Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Apr/16/2021 24 7
Alpha-1 antitrypsin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/19/2021 3 0
Bromhexine hydrochloride Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/15/2021 3 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 14
Interferon alpha Recommended by China's NHC Guidelines Used to treat other disease Antiviral Jan/27/2021 5 1
Cobicistat Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/17/2020 3 0
Darunavir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/11/2020 6 1
Leronlimab Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/20/2020 2 0